Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma

SIMPLE SUMMARY: Cholangiocarcinoma (CCA) is an architecturally complex and highly heterogeneous tumour and is difficult to diagnose at early stages due to its late onset and asymptomatic nature. Recent studies have focused on the Fibroblast Growth Factor Receptors (FGFRs), a sub-family of Tyrosine K...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramanian, Brinda, Yacqub-Usman, Kiren, Venkatraman, Simran, Myint, Kyaw Zwar, Juengsamarn, Jitlada, Sarkhampee, Poowanai, Lertsawatvicha, Nithi, Sripa, Jittiyawadee, Kuakpaetoon, Thiti, Suriyonplengsaeng, Chinnawut, Wongprasert, Kanokpan, Grabowska, Anna M., Bates, David O., Janvilisri, Tavan, Tohtong, Rutaiwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177182/
https://www.ncbi.nlm.nih.gov/pubmed/37173994
http://dx.doi.org/10.3390/cancers15092528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177182/
https://www.ncbi.nlm.nih.gov/pubmed/37173994
http://dx.doi.org/10.3390/cancers15092528

Ejemplares similares